Ghent University Academic Bibliography

Show Sort by

Your filters: cql: affiliation exact GE cql: author exact 801001212658

Add to list
- Journal Article
- A1
- open access
Endotypes of chronic rhinosinusitis based on inflammatory and remodeling factors

Xiangdong Wang, Yutong Sima, Yan Zhao, Nan Zhang (UGent) , Ming Zheng, Kun Du, Min Wang, Yue Wang, Yun Hao, Ying Li, et al.

(2023) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 151(2). p.458-468
Add to list
- Journal Article
- A1
- open access
Differential protease content of mast cells and the processing of IL-33 in Alternaria alternata induced allergic airway inflammation in mice

Olga Krysko (UGent) , Darya Korsakova, Andrea Renate Teufelberger, Amse De Meyer (UGent) , Jill Steels (UGent) , Natalie De Ruyck (UGent) , Judith van Ovost (UGent) , Sharon Van Nevel (UGent) , Gabriële Holtappels (UGent) , Frauke Coppieters (UGent) , et al.

(2023) FRONTIERS IN IMMUNOLOGY. 14.
Add to list
Effects of biologics treatment in type 2-high chronic rhinosinusitis with nasal polyp patients

Sharon Van Nevel (UGent) , Tim Meese (UGent) , Gabriële Holtappels (UGent) , Natalie De Ruyck (UGent) , Stijn Vanhee (UGent) , Nan Zhang (UGent) , Filip Van Nieuwerburgh (UGent) and Claus Bachert (UGent)

(2023) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 151(2, Supplement 1). p.AB187-AB187
Add to list
Phase 3b randomized controlled trial of fevipiprant in patients with nasal polyposis with asthma (THUNDER)

Philippe Gevaert (UGent) , Claus Bachert (UGent) , Jorge Fernando Maspero, Mandy Cuevas, David Steele, Sandip Acharya and Pablo Altman

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 149(5). p.1675-1682.e3
Add to list
- Journal Article
- A1
- open access
Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study

Philippe Gevaert (UGent) , Rebecca Saenz, Jonathan Corren, Joseph K. Han, Joaquim Mullol, Stella E. Lee, Randall A. Ow, Rui Zhao, Monet Howard, Kit Wong, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 149(3). p.957-965.e3
Add to list
- Conference Paper
- C3
Mepolizumab and benralizumab reduce eosinophilic inflammation in nasal polyposis, do neutrophils take over?

Tim Delemarre (UGent) , Elien Gevaert (UGent) , Gabriële Holtappels (UGent) , Nan Zhang (UGent) , Hans Nauwynck and Claus Bachert (UGent)

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 149(2, Supplement S). p.AB161-AB161
Add to list
Online education yields significant gains in physicians' knowledge of eosinophil-associated disorders

Adriana Stan, Gillian Griffith, Juliette Vandenbroucque and Claus Bachert (UGent)

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 149(2, Supplement S). p.AB195-AB195
Add to list
- Journal Article
- A1
- open access
Association between outdoor air pollution and chronic rhinosinusitis patient reported outcomes

S. Peeters, C. Wang, E. M. Bijnens, D. M. A. Bullens, W. J. Fokkens, Claus Bachert (UGent) , Peter Hellings (UGent) , T. S. Nawrot and S. F. Seys

(2022) ENVIRONMENTAL HEALTH. 21(1).
Add to list
- Journal Article
- A1
- open access
A diagnostic model for predicting type 2 nasal polyps using biomarkers in nasal secretion

Zaichuan Wang, Qiqi Wang, Su Duan, Yuling Zhang, Limin Zhao, Shujian Zhang, Liusiqi Hao, Yan Li, Xiangdong Wang, Chenshuo Wang, et al.

(2022) FRONTIERS IN IMMUNOLOGY. 13.
Add to list
- Journal Article
- A1
- open access
Local immunoglobulin E in nasal polyps : role and modulation

Yang Shen, Nan Zhang (UGent) , Yucheng Yang, Suling Hong and Claus Bachert (UGent)

(2022) FRONTIERS IN IMMUNOLOGY. 13.

Academic Bibliography

Endotypes of chronic rhinosinusitis based on inflammatory and remodeling factors

Differential protease content of mast cells and the processing of IL-33 in Alternaria alternata induced allergic airway inflammation in mice

Effects of biologics treatment in type 2-high chronic rhinosinusitis with nasal polyp patients

Phase 3b randomized controlled trial of fevipiprant in patients with nasal polyposis with asthma (THUNDER)

Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study

Mepolizumab and benralizumab reduce eosinophilic inflammation in nasal polyposis, do neutrophils take over?

Online education yields significant gains in physicians' knowledge of eosinophil-associated disorders

Association between outdoor air pollution and chronic rhinosinusitis patient reported outcomes

A diagnostic model for predicting type 2 nasal polyps using biomarkers in nasal secretion

Local immunoglobulin E in nasal polyps : role and modulation

Contents

Support

Contact